Gibson believes Nobilis will generate EBITDA of $52.8-million on revenue of $281.1-million in fiscal 2016. He expects these numbers will improve to EBITDA of $67.6-million on a topline of 343.6-million the following year.
http://www.cantechletter.com/2017/01/nobilis-health-acquisition-hamilton-vein-center-gets-thumbs-pi/
https://finance.yahoo.com/news/nobilis-acquire-texas-based-vascular-100000645.html
Previous acquisition resulted in
Updated Full Year 2016 Guidance
The Company raised its full year 2016 guidance for total revenues and adjusted EBITDA1 to reflect the closing of the acquisition of AVVC and ACMIS. Full year 2016 total revenues are now expected to be $281 million, up from $275 million. Full year Adjusted EBITDA1 is now expected to be $53 million, up from $51 million
http://investors.nobilishealth.com/investors/press-releases/press-release-details/2016/Nobilis-Health-Corp-Announces-Completion-of-Acquisition-of-Arizona-Vascular-Clinics--New-825-Million-Credit-Facility/default.aspx
1c
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM